NCT06310902View on ClinicalTrials.gov

Single-cell Sequencing Analysis of Resectable/Borderline Resectable Pancreatic Cancer Patients

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

March 1, 2026

Study Completion Date

September 1, 2026

Conditions
Pancreatic Neoplasms
Interventions
DIAGNOSTIC_TEST

Single-cell Sequencing Analysis

Identification of rare cell populations, the characterization of cell types and subtypes, and the discovery of novel cell states.

Trial Locations (1)

350001

RECRUITING

Fujian Medical University Union Hospital, Fuzhou

All Listed Sponsors
lead

Fujian Medical University Union Hospital

OTHER